BioCentury
ARTICLE | Clinical News

U.S. Bioscience regulatory update

May 6, 1996 7:00 AM UTC

Canada approved Ethyol (amifostine) for use as a cytoprotective agent against the cumulative renal toxicities associated with cisplatin and the hematological toxicities associated with cyclophosphami...